Martinsried, Bayern, Germany Ingenium Pharamceutical appeared to be the Corporate Investor, which was created in 1998. The main department of described Corporate Investor is located in the Martinsried. The venture was found in Europe in Germany.
The typical case for the fund is to invest in rounds with 1 participant. In the next rounds fund is usually obtained by TVM Capital, Life Sciences Partners, IBG Beteiligungsgesellschaft Sachsen-Anhalt.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Among the most popular fund investment industries, there are Therapeutics, Biopharma. Among the various public portfolio startups of the fund, we may underline Vivoryon Therapeutics
The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007. The fund is constantly included in less than 2 deals per year.
| Fund Name | Location |
| .Invest Ukraine | - |
| Abbey International Finance | - |
| Ad Hack Ventures | Japan, Tokyo |
| BroadOak Capital Partners | Bethesda, Maryland, United States |
| C31Ventures | Central, Central Region, Singapore |
| East Midlands Business Angels | Newark Upon Trent, Nottinghamshire, United Kingdom |
| Fremont Group | California, San Francisco, United States |
| Global Atlantic | Atlanta, Georgia, United States |
| IMM Private Equity | Seoul, Seoul-t'ukpyolsi, South Korea |
| IUGO Ventures | Canada, Montréal, Quebec |
| Leadiant Biosciences | Gaithersburg, Maryland, United States |
| Magellan Health Services | Avon, Connecticut, United States |
| Nextpoint | Chicago, Illinois, United States |
| Percival Participations | Rotterdam, The Netherlands, Zuid-Holland |
| Redbrick | British Columbia, Canada, Victoria |
| Ridgebox | Astoria, New York, United States |
| Shenzhenshi Qianhai Derun Fujiang Touzi Guanli Co., Ltd. | China, Guangdong, Shenzhen |
| Spartech Ventures | Dubai, United Arab Emirates |
| TIBCORP | Central, Central Region, Singapore |
| Wit Capital | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vivoryon Therapeutics | $20M | 25 Jun 2007 | Saxony-Anhalt |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vivoryon Therapeutics | $20M | 25 Jun 2007 | Saxony-Anhalt |
